MannKind Corp (MNKD):企業の財務・戦略的SWOT分析

◆英語タイトル:MannKind Corp (MNKD) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH44250FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

MannKind Corp (MNKD) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

MannKind Corp (MannKind) is a biopharmaceutical company that develops and commercializes inhaled therapeutic products for patients suffering from diabetes and pulmonary arterial hypertension. Its flagship product, Afrezza is a rapid-action inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. It consists of a dry powder formulation of human insulin delivered from small and portable inhaler. The company develops products based on its proprietary Technosphere formulation technology. The company has manufacturing facility in Danbury, Connecticut and sells product to wholesale distributors and specialty pharmacies in the US. MannKind is headquartered in Westlake Village, California, the US.

MannKind Corp Key Recent Developments

Mar 10,2021: MannKind Corporation to Participate in Oppenheimer’s 31st Annual Healthcare Conference
Feb 25,2021: MannKind reports 2020 fourth quarter and full year financial results
Feb 18,2021: MannKind Corporation to Participate in 2021 SVB Leerink Global Healthcare Conference
Dec 10,2020: James S. Shannon transitions to chairman of the board of directors for MannKind
Dec 01,2020: MannKind and MidCap amend credit facility

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
MannKind Corp – Key Facts
MannKind Corp – Key Employees
MannKind Corp – Key Employee Biographies
MannKind Corp – Major Products and Services
MannKind Corp – History
MannKind Corp – Company Statement
MannKind Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
MannKind Corp – Business Description
Business Segment: Collaborations and Services
Overview
Performance
Business Segment: Commercial Product Sales
Overview
Performance
R&D Overview
MannKind Corp – Corporate Strategy
MannKind Corp – SWOT Analysis
SWOT Analysis – Overview
MannKind Corp – Strengths
MannKind Corp – Weaknesses
MannKind Corp – Opportunities
MannKind Corp – Threats
MannKind Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
MannKind Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
MannKind Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
MannKind Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 10, 2021: MannKind Corporation to Participate in Oppenheimer’s 31st Annual Healthcare Conference
Feb 25, 2021: MannKind reports 2020 fourth quarter and full year financial results
Feb 18, 2021: MannKind Corporation to Participate in 2021 SVB Leerink Global Healthcare Conference
Dec 10, 2020: James S. Shannon transitions to chairman of the board of directors for MannKind
Dec 01, 2020: MannKind and MidCap amend credit facility
Nov 30, 2020: Sabrina Kay appointed to MannKind Board of Directors
Nov 04, 2020: MannKind reports 2020 third quarter financial results
Aug 31, 2020: Kevin Kaiserman joins MannKind as Vice President, Medical Affairs and Safety
Aug 05, 2020: MannKind reports 2020 second quarter financial results
Jul 20, 2020: Alejandro Galindo joins MannKind as Chief Commercial Officer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
MannKind Corp, Key Facts
MannKind Corp, Key Employees
MannKind Corp, Key Employee Biographies
MannKind Corp, Major Products and Services
MannKind Corp, History
MannKind Corp, Other Locations
MannKind Corp, Subsidiaries
MannKind Corp, Key Competitors
MannKind Corp, Ratios based on current share price
MannKind Corp, Annual Ratios
MannKind Corp, Annual Ratios (Cont...1)
MannKind Corp, Annual Ratios (Cont...2)
MannKind Corp, Interim Ratios
MannKind Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
MannKind Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
MannKind Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[MannKind Corp (MNKD):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bose Corporation:企業の戦略・SWOT・財務情報
    Bose Corporation - Strategy, SWOT and Corporate Finance Report Summary Bose Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Rexel S.A.:企業の戦略・SWOT・財務分析
    Rexel S.A. - Strategy, SWOT and Corporate Finance Report Summary Rexel S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • A.P. Eagers Limited:企業の戦略・SWOT・財務情報
    A.P. Eagers Limited - Strategy, SWOT and Corporate Finance Report Summary A.P. Eagers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Genome Institute of Singapore:医療機器:M&Aディール及び事業提携情報
    Summary Genome Institute of Singapore (GIS) is a research institute that provides research programs and services in different areas. The institute concentrates on genomic sciences to improve public health and prosperity in Singapore. It operates technology and comprises early career researchers such …
  • Marina Biotech, Inc.:企業の戦略・SWOT・財務情報
    Marina Biotech, Inc. - Strategy, SWOT and Corporate Finance Report Summary Marina Biotech, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Regis Corporation (RGS):企業の財務・戦略的SWOT分析
    Regis Corporation (RGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • TRACON Pharmaceuticals Inc (TCON):製薬・医療:M&Aディール及び事業提携情報
    Summary TRACON Pharmaceuticals Inc (TRACON) is a biopharmaceutical company that develops and commercializes targeted therapies for cancer, age-related macular degeneration and fibrotic diseases. The company offers pipeline products such as TRC105, TRC102, TRC253, TRC694, and TRC205. Its lead product …
  • Greatcell Solar Ltd (GSL)-エネルギー分野:企業M&A・提携分析
    Summary Greatcell Solar Ltd (Greatcell Solar), formerly Dyesol Limited, is a renewable energy company that develops and commercializes Perovskite Solar Cells (PSC) or solid-state dye solar cell (DSC), the third generation photovoltaic technology. The company develops a range of PSC chemicals, compon …
  • QinetiQ Group Plc:企業の戦略・SWOT・財務情報
    QinetiQ Group Plc - Strategy, SWOT and Corporate Finance Report Summary QinetiQ Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • The Hartz Mountain Corporation:企業の戦略・SWOT・財務分析
    The Hartz Mountain Corporation - Strategy, SWOT and Corporate Finance Report Summary The Hartz Mountain Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Tesla Inc (TSLA):企業の財務・戦略的SWOT分析
    Tesla Inc (TSLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Orly International, Inc.:企業の戦略・SWOT・財務分析
    Orly International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Orly International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Mobile Tornado Group Plc (MBT):企業の財務・戦略的SWOT分析
    Summary Mobile Tornado Group Plc (Mobile Tornado) is a technology company that offers communication services. The company offers solutions such as instant messaging solutions, voice communication, one-to-one and one-to-many; and instant alert that enables workforce to raise alerts in a range of situ …
  • H. Butting GmbH & Co KG:企業の戦略・SWOT・財務情報
    H. Butting GmbH & Co KG - Strategy, SWOT and Corporate Finance Report Summary H. Butting GmbH & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Maruti Suzuki India Limited:企業の戦略・SWOT・財務分析
    Maruti Suzuki India Limited - Strategy, SWOT and Corporate Finance Report Summary Maruti Suzuki India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Burgan Bank Sak:企業の戦略・SWOT・財務分析
    Burgan Bank Sak - Strategy, SWOT and Corporate Finance Report Summary Burgan Bank Sak - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Inotek Pharmaceuticals Corp (RCKT):製薬・医療:M&Aディール及び事業提携情報
    Summary Inotek Pharmaceuticals Corp (IPC) is a clinical-stage biopharmaceutical company that focus on the discovery and development of novel therapeutics for the treatment of glaucoma and serious diseases of the eye. The company’s trabodenoson is a selective adenosine mimetic that stimulates a speci …
  • MEG Energy Corp (MEG):石油・ガス:M&Aディール及び事業提携情報
    Summary MEG Energy Corp (MEG) is an oil and gas company that develops and produces from oil sands. The company operates Christina lake, May River and Surmont project. Its technologies comprise steam-assisted gravity drainage, cogeneration, Hi-Q field pilot and eMSAGP. MEG's Christina Lake project is …
  • Isuzu Motors Limited:企業の戦略・SWOT・財務情報
    Isuzu Motors Limited - Strategy, SWOT and Corporate Finance Report Summary Isuzu Motors Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • First Pacific Co Ltd (142):企業の財務・戦略的SWOT分析
    First Pacific Co Ltd (142) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆